The blood and bone marrow transplantation center at Apollo Hospitals, India has performed over 1500 transplants with an excellent success rate. Apollo Hospitals, India is also a trusted name in BMT for international patients, as the hospital has not just a highly qualified BMT team, but also very stringent infection control norms which are critical for BMT patients. BMT treatment is available at Apollo Hospitals at Chennai, New Delhi, Hyderabad, Ahmedabad and Kolkata.
The procedure serves mainly 3 purposes
- Replacing a missing gene e.g. in Thalassemia, Sickle cell disease and many genetic disorders. These are diseases where the person is otherwise normal, except for one missing gene, and replacing that gene is curative.
- Allows use of high doses of anticancer therapies, which may lead to loss of bone marrow. Without stem cells support, marrow will recover only after a long time, resulting in high complication rate from infections or bleeding. Infused stem cells provide early recovery of blood cells. It considerably lowers the risk of low blood counts due to marrow suppression. Thus it is one form of “Supportive Therapy” and not a treatment of cancer by itself. This is the case in Autologous (self) transplant and in majority of Allogeneic transplants.
- Some “Graft versus Disease activity”, more commonly known as “Graft v Leukemia effect” in Allogeneic transplant, especially evident in chronic myeloid leukemia.